On August 17, OmniAb, Inc. (NASDAQ:OABI) announced a global collaboration and license agreement with Eli Lilly and Company ...
Bank of Nova Scotia’s strong Q3 results, stable CET1 and favorable curve dynamics—but cyclical ADR/valuation risks remain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results